Abstract: An oil deflector comprising: a cylindrical portion; a first guide surface extending radially outward from the cylindrical portion; and a second guide surface that is located on a radially outer side of the cylindrical portion and extends in a direction that crosses an outer peripheral surface of the cylindrical portion and the first guide surface.

Abstract: An oil deflector comprising: a cylindrical portion; a first guide surface extending radially outward from the cylindrical portion; and a second guide surface that is located on a radially outer side of the cylindrical portion and extends in a direction that crosses an outer peripheral surface of the cylindrical portion and the first guide surface.

Abstract: A pressurization device has a housing accommodating a plurality of battery cells and a plurality of spacers fixed to housing at even intervals in the thickness direction and forming bag shapes capable of expanding and contracting in accordance with air pressure. In a state in which the spacers have been contracted, each space larger than the dimensions of the battery cells in the thickness direction is maintained between adjacent spacers. In a state in which the spacers have been expanded by increasing the air pressure inside the spacers by an air apparatus, the adjacent spacers pressurize the battery cells in the thickness direction.

Abstract: A pressurization device has a housing accommodating a plurality of battery cells and a plurality of spacers fixed to housing at even intervals in the thickness direction and forming bag shapes capable of expanding and contracting in accordance with air pressure. In a state in which the spacers have been contracted, each space larger than the dimensions of the battery cells in the thickness direction is maintained between adjacent spacers. In a state in which the spacers have been expanded by increasing the air pressure inside the spacers by an air apparatus, the adjacent spacers pressurize the battery cells in the thickness direction.

Abstract: A sender golf bag for storing golf clubs allowing the golf clubs to be held at specified positions, a specified one of these golf clubs to be removed at a glance, and the golf clubs to be stably held to prevent damage, comprising a body and a cover body. The body further comprises an opening part vertically formed from the generally upper to the generally lower end of the slender bag and having rigidity to retain its original shape, a golf club holding means holding and storing the golf clubs, and a connection means installed near the opening part to contribute to the easy attachment/detachment of a cover body. The cover body covering the body further comprises an opening part formed in a shape matching the opening part of the body and having rigidity to retain its original shape and a connection means matching the connection means of the body to contribute to the easy attachment/detachment thereof.

Abstract: To provide a novel compound of the formula: [wherein A1 ix a 5 or 6-membered ring which may be substituted by a group not containing a cyclic group, A2 is an aromatic ring which may be substituted, X is a divalent group, Y is a nitrogen atom or a methine group, Z is an ethenylene which may be substituted or ethynylene, R is a heterocyclic group which may be substituted, provided that 3,4-dihydro-6-[3-(1H-imidazol-1-yl)-1-propenyl]-2(1H)-quinolone and 2-[3-[5-ethyl-6-methyl-2-(benzyloxy)-3-pyridyl]-1-propenyl]benzoxazole are excluded.], or a salt thereof which has steroid C17,20-lyase inhibitory activity, and is useful for preventing and treating mammals suffering from, for example, primary cancer of malignant tumor, its metastasis and recurrence thereof.

Abstract: Disclosed are intermediates for the preparation of novel aminocoumaran derivatives of the general formula (I): ##STR1## wherein R.sup.1 and R.sup.2 are a hydrogen atom, an acyl group, an alkoxycarbonyl group, an aliphatic group or aromatic group; R.sup.3, R.sup.4 and R.sup.5 are an optionally acylated hydroxyl, optionally substituted amino group, alkoxy group or aliphatic group, or two of R.sup.3, R.sup.4 and R.sup.5 may be linked together to form a carbocyclic group; R.sup.6 and R.sup.7 are an aliphatic group and at least one of them has a methylene group at the .alpha.-position; R.sup.8 and R.sup.9 are a hydrogen atom or an aliphatic group or aromatic group, or a salt thereof is useful for medicines for preventing and treating various diseases such as arterial sclerosis, hepatopathy, cerebrovascular diseases and the like.

Abstract: A novel compound of the formula:A--Z--Ar.sup.1 1'CO--Ar.sup.2wherein A is a condensed pyrimidinone or condensed pyridazinone ring; Ar.sup.1 and Ar.sup.2 are independently a ring; Z is a divalent group, or a salt thereof which have an excellent antitumor activity.

Abstract: A novel aminocoumaran derivative of the general formula (I): ##STR1## wherein R.sup.1 and R.sup.2 are a hydrogen atom, an acyl group, an alkoxycarbonyl group, an aliphatic group or aromatic group; R.sup.3, R.sup.4 and R.sup.5 are an optionally acylated hydroxyl optionally substituted amino group, alkoxy group or aliphatic group, or two of R.sup.3, R.sup.4 and R.sup.5 may be linked together to form a carbocyclic group; R.sup.6 and R.sup.7 are an aliphatic group and at least one of them has a methylene group at the .alpha.-position; R.sup.8 and R.sup.9 are a hydrogen atom or an aliphatic group or aromatic group, or a salt thereof is useful for medicines for preventing and treating various diseases such as arterial sclerosis, hepatopathy, cerebrovascular diseases and the like.

Abstract: A compound of the invention is represented by the formula: ##STR1## wherein R.sup.1 and R.sup.2 are the same or different, an acyl group; R.sup.3, R.sup.4, R.sup.6 and R.sup.7 are the same or different, hydrogen or an alkyl group; R.sup.5 is hydrogen, an alkyl group or a hydroxyl group which may optionally be protected, or R.sup.4 and R.sup.5 are combined to form a chemical bond; X is a carbonyl group or a sulfonyl group; Y is an amino acid sequence consisting of 1 to 7 amino acid residues which may optionally be protected and having optionally an intervening --SO.sub.2 NH--; n is an integer of 0 to 2, or a salt thereof.

Abstract: A novel aminocoumaran derivatives of the general formula (I): ##STR1## wherein R.sup.1 and R.sup.2 are a hydrogen atom, an acyl group, an alkoxycarbonyl group, an aliphatic group or aromatic group; R.sup.3, R.sup.4 and R.sup.5 are an optionally acylated hydroxyl optionally substituted amino group, alkoxy group or aliphatic group, or two of R.sup.3, R.sup.4 and R.sup.5 may be linked together to form a carbocyclic group; R.sup.6 and R.sup.7 are an aliphatic group and at least: one of them has a methylene group at the .alpha.-position; R.sup.8 and R.sup.9 are a hydrogen atom or an aliphatic group or aromatic group, or a salt thereof is useful for medicines for treating various diseases such as arterial sclerosis, hepatopathy, cerebrovascular diseases and the like.

Abstract: A novel aminocoumaran derivatives of the general formula (I): ##STR1## wherein R.sup.1 and R.sup.2 are a hydrogen atom, an acyl group, an alkoxycarbonyl group, an aliphatic group or aromatic group; R.sup.3 R.sup.4 and R.sup.5 are an optionally acylated hydroxyl optionally substituted amino group, alkoxy group or aliphatic group, or two of R.sup.3, R.sup.4 and R.sup.5 may be linked together to form a carbocyclic group; R.sup.6 and R.sup.7 are an aliphatic group and at least one of them has a methylene group at the .alpha.-position; R.sup.8 and R.sup.9 are a hydrogen atom or an aliphatic group or aromatic group, or a salt thereof is useful for medicines for preventing and treating various diseases such as arterial schleosis, hepatopathy, cerebrovascular diseases and the like.

Abstract: An upper column address strobe signal and a lower column address strobe signal applied to a dynamic RAM are 180.degree. out of phase from each other. Data of n bits are read out from a memory cell array at a time. The data read out from memory cell array is divided into two bit groups and applied to an upper IO buffer and a lower IO buffer. Upper IO buffer and lower IO buffer latch sequentially the upper bit group and the lower bit group and output these groups to a data transmission bus in response to the upper column address strobe signal and the lower column address strobe signal.

Abstract: New thiazolo[5,4-b]azepine compounds represented by ##STR1## wherein R.sup.1 is a hydrogen atom, an aliphatic group which may be substituted, a carboxylic acyl group which may be substituted or a sulfonic acyl group which may be substituted; R.sup.2 is a hydrogen atom, an aromatic group which may be substituted or an aliphatic group which may be substituted, which are capable of e.g., inhibiting lipoperoxide formation.

Abstract: There is disclosed a DRAM having a 16 bit configuration which can be used for either a 2CAS/1WE type or a 1CAS/2WE type. The type of DRAM to be used is determined by whether there is a connection through a gold wire between a predetermined bonding pad and a lead for ground potential. Depending on the state of the connection of the bounding pad, conversion buffer converts externally applied control clock signals to internal control clock signals for either the 2CAS/1WE or the 1CAS/2WE. A clock generator not shown is operated in response to the converted internal control clock signals. The type of DRAM to be used is determined by whether there is a connection through a gold wire which is provided at the final step in a manufacturing process, so that the manufacturing processes are unified and therefore the type of DRAM to be used can be altered quickly depending on a drastically changing demand. In addition, efficiency in manufacturing a DRAM is enhanced.

Abstract: A novel condensed thiazole derivative of the formula [I]: ##STR1## wherein A is a single bond or CH.sub.2 ; R.sup.1 is hydrogen atom, or an optionally substituted aliphatic, carboxylic acyl or sulfonic acyl group; and R.sup.2 is hydrogen atom, or an optionally substituted aromatic cyclic or aliphatic group, or a salt thereof. The compound [I] is useful for medicines for preventing and treating various diseases such as cancer, arterial sclerosis, hepatopathy, cerebrovascular diseases, inflammatory and the like. A process of the compound of the formula [I] or a salt thereof and a pharmaceutical composition comprising the compound of the formula [I] or a pharmaceutically acceptable salt thereof as an active component are also disclosed.

Abstract: New thiazolo[5,4-b]azepine compounds represented by ##STR1## wherein R.sup.1 is a hydrogen atom, an aliphatic group which may be substituted, a carboxylic acyl group which may be substituted or a sulfonic acyl group which may be substituted; R.sup.2 is a hydrogen atom, an aromatic group which may be substituted or an aliphatic group which may be substituted, which are capable of e.g., inhibiting lipoperoxide formation.

Abstract: New thiazolo[5,4-b]azepine compounds represented by ##STR1## wherein R.sup.1 is a hydrogen atom, an aliphatic group which may be substituted, a carboxylic acyl group which may be substituted or a sulfonic acyl group which may be substituted; R.sup.2 is a hydrogen atom, an aromatic group which may be substituted or an aliphatic group which may be substituted, which are capable of e.g., inhibiting lipoperoxide formation.

Abstract: A novel chromone derivative having a strong antitumor activity of the general formula: ##STR1## wherein R.sup.1 is an unsaturated alkyl or cycloalkyl group having 3 to 7 carbon atoms; R.sup.2 is hydrogen atom or a halogen atom; R.sup.3 is hydrogen atom or a lower alkyl group; and X is carboxyl group, or its salt, ester or amide.

Abstract: A substrate bias circuit controls application of a conventional substrate charge pump to the substrate of a semiconductor integrated circuit to prevent latching up of parasitic transistors at the time of turn on of power to the integrated circuit. The substrate bias circuit comprises a filed effect transistor having its source and drain electrodes connected between substrate and charge pump. The gate electrode of the transistor is driven through an RC circuit by the power supply to turn on the transistor for a predetermined time period at the time power is initially applied to the integrated circuit. There is no latching up of the parasitic transistors because application of positive bias voltage to the substrate during turn-on is prevented.